1-20 of 23
Sylvie Ménard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P4-15-06: Correlation between ERBB2 mRNA levels, HER2-dependence and susceptibility to trastuzumab in human breast cancer

Elda Tagliabue, Viola Regondi, Loris De Cecco, Serenella M Pupa, Manuela Campiglio, Maria Luisa Carcangiu, Sylvie Ménard, Tiziana Triulzi
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-15-06.
https://doi.org/10.1158/1538-7445.SABCS14-P4-15-06
Published: 01 May 2015
View article titled, Abstract P4-15-06: Correlation between ERBB2 mRNA levels, HER2-dependence and susceptibility to trastuzumab in human breast cancer
Journal Articles

Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab

Lorenzo Castagnoli, Manuela Iezzi, Gaia C. Ghedini, Valentina Ciravolo, Giulia Marzano, Alessia Lamolinara, Roberta Zappasodi, Patrizia Gasparini, Manuela Campiglio, Augusto Amici, Claudia Chiodoni, Arianna Palladini, Pier Luigi Lollini, Tiziana Triulzi, Sylvie Menard, Patrizia Nanni, Elda Tagliabue, Serenella M. Pupa
Journal: Cancer Research
Series: Author Choice
Cancer Res (2014) 74 (21): 6248–6259.
https://doi.org/10.1158/0008-5472.CAN-14-0983
Published: 30 October 2014
View article titled, Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab
Open the PDF for Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab in another window
Includes: Supplementary data
Journal Articles

TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects

Michele Sommariva, Loris De Cecco, Michelandrea De Cesare, Lucia Sfondrini, Sylvie Ménard, Cecilia Melani, Domenico Delia, Nadia Zaffaroni, Graziella Pratesi, Valentina Uva, Elda Tagliabue, Andrea Balsari
Journal: Cancer Research
Cancer Res (2011) 71 (20): 6382–6390.
https://doi.org/10.1158/0008-5472.CAN-11-1285
Published: 12 October 2011
View article titled, TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects
Open the PDF for TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects in another window
Includes: Supplementary data
Journal Articles

Abstract #832: Resistance is an inappropriate concept for biological drug such as trastuzumab

Manuela Campiglio, Andrea Balsari, Elisa Ferri, Marco Sandri, Rosaria Bufalino, Sylvie Menard, Elda Tagliabue
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 832.
Published: 01 May 2009
View article titled, Abstract #832: Resistance is an inappropriate concept for biological drug such as trastuzumab
Journal Articles

Abstract #1392: miR-205: A new tumor suppressor in breast cancer

Marilena Iorio, Claudia Piovan, Patrizia Casalini, Gianpiero Di Leva, Andrea Merlo, Tiziana Triulzi, Sylvie Ménard, Carlo Croce, Elda Tagliabue
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1392.
Published: 01 May 2009
View article titled, Abstract #1392: miR-205: A new tumor suppressor in breast cancer
Journal Articles

Trastuzumab targets tumor-initiating cells of HER2-positive tumors

Elda Tagliabue, Alessandra Magnifico, Luisa Albano, Domenico Delia, Patrizia Gasparini, Gabriella Sozzi, Sylvie Menard, Stefano Campaner
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4605.
Published: 01 May 2008
View article titled, Trastuzumab targets tumor-initiating cells of HER2-positive tumors
Journal Articles

Involvement of miR-205 in human breast cancer

Marilena Iorio, Gianpiero Di Leva, Patrizia Casalini, Claudia Piovan, Rosaria Orlandi, Tiziana Triulzi, Elda Tagliabue, Carlo Croce, Sylvie Menard
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5045.
Published: 01 May 2008
View article titled, Involvement of miR-205 in human breast cancer
Journal Articles

Regulation of Breast Cancer Response to Chemotherapy by Fibulin-1

Serenella M. Pupa, Sarah Giuffré, Fabio Castiglioni, Lorenzo Bertola, Marco Cantú, Italia Bongarzone, Paola Baldassari, Roberta Mortarini, W. Scott Argraves, Andrea Anichini, Sylvie Menard, Elda Tagliabue
Journal: Cancer Research
Cancer Res (2007) 67 (9): 4271–4277.
https://doi.org/10.1158/0008-5472.CAN-06-4162
Published: 04 May 2007
View article titled, Regulation of Breast Cancer Response to Chemotherapy by Fibulin-1
Open the PDF for Regulation of Breast Cancer Response to Chemotherapy by Fibulin-1 in another window
Includes: Supplementary data
Journal Articles

The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

Monica R. Maiello, Antonella De Luca, Adele Carotenuto, Manuela Campiglio, Maria Napolitano, Amelia D’Alessio, Sylvie Menard, Nicola Normanno
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1115.
Published: 15 April 2006
View article titled, The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
Journal Articles

Identification and characterization of tumor stem cells from ovarian and breast carcinoma cell lines

Alessandra Magnifico, Elda Tagliabue, Serenella M. Pupa, Sylvie Menard
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 74–75.
Published: 15 April 2006
View article titled, Identification and characterization of tumor stem cells from ovarian and breast carcinoma cell lines
Journal Articles

Therapeutic Synergism of Gemcitabine and CpG-Oligodeoxynucleotides in an Orthotopic Human Pancreatic Carcinoma Xenograft

Graziella Pratesi, Giovanna Petrangolini, Monica Tortoreto, Alessandro Addis, Sara Belluco, Anna Rossini, Silvia Selleri, Cristiano Rumio, Sylvie Menard, Andrea Balsari
Journal: Cancer Research
Cancer Res (2005) 65 (14): 6388–6393.
https://doi.org/10.1158/0008-5472.CAN-05-0602
Published: 15 July 2005
View article titled, Therapeutic Synergism of Gemcitabine and CpG-Oligodeoxynucleotides in an Orthotopic Human Pancreatic Carcinoma Xenograft
Open the PDF for Therapeutic Synergism of Gemcitabine and CpG-Oligodeoxynucleotides in an Orthotopic Human Pancreatic Carcinoma Xenograft in another window
Journal Articles

Gemcitabine plus CpG-oligodeoxinucleotides: Strong efficacy against a human pancreatic orthotopic tumor xenograft

Giovanna Petrangolini, Monica Tortoreto, Sylvie Menard, Lucia Sfondrini, Anna Rossini, Silvia Selleri, Alessandro Addis, Andrea Balsari, Graziella Pratesi
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 169.
Published: 01 May 2005
View article titled, Gemcitabine plus CpG-oligodeoxinucleotides: Strong efficacy against a human pancreatic orthotopic tumor xenograft
Journal Articles

Decrease aggressiveness of HER2-positive breast carcinomas with current therapies

Sylvie Menard, Elda Tagliabue, Roberto Agresti, Patrizia Casalini, Serenella Pupa, Manuela Campiglio, Andrea Balsari
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 512.
Published: 01 May 2005
View article titled, Decrease aggressiveness of HER2-positive breast carcinomas with current therapies
Journal Articles

Cooperative inhibitory effect of gefitinib (‘Iressa’, ZD1839) in combination with rofecoxib on human breast cancer cell growth

Antonella De Luca, Monica R. Maiello, Francesco Perrone, Manuela Campiglio, Mario Mancino, Sylvie Menard, Nicola Normanno
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 894.
Published: 01 April 2004
View article titled, Cooperative inhibitory effect of gefitinib (‘Iressa’, ZD1839) in combination with rofecoxib on human breast cancer cell growth
Journal Articles

FHIT Loss of Function in Human Primary Breast Cancer Correlates with Advanced Stage of the Disease

Manuela Campiglio, Yuri Pekarsky, Sylvie Menard, Elda Tagliabue, Silvana Pilotti, Carlo M. Croce
Journal: Cancer Research
Cancer Res (1999) 59 (16): 3866–3869.
Published: 15 August 1999
View article titled, <em>FHIT</em> Loss of Function in Human Primary Breast Cancer Correlates with Advanced Stage of the Disease
Open the PDF for <em>FHIT</em> Loss of Function in Human Primary Breast Cancer Correlates with Advanced Stage of the Disease in another window
Journal Articles

Oral Administration of Anti-Doxorubicin Monoclonal Antibody Prevents Chemotherapy-induced Gastrointestinal Toxicity in Mice

Daniele Morelli, Sylvie Ménard, Maria I. Colnaghi, Andrea Balsari
Journal: Cancer Research
Cancer Res (1996) 56 (9): 2082–2085.
Published: 01 May 1996
View article titled, Oral Administration of Anti-Doxorubicin Monoclonal Antibody Prevents Chemotherapy-induced Gastrointestinal Toxicity in Mice
Open the PDF for Oral Administration of Anti-Doxorubicin Monoclonal Antibody Prevents Chemotherapy-induced Gastrointestinal Toxicity in Mice in another window
Journal Articles

A Comparative Study of p53 Gene Mutations, Protein Accumulation, and Response to Cisplatin-based Chemotherapy in Advanced Ovarian Carcinoma

Sabina C. Righetti, Gabriella Della Torre, Silvana Pilotti, Sylvie Ménard, Francesca Ottone, Maria I. Colnaghi, Marco A. Pierotti, Cinzia Lavarino, Mariagrazia Cornarotti, Saro Oriana, Silvia Böhm, Gian Luigi Bresciani, Giambattista Spatti, Franco Zunino
Journal: Cancer Research
Cancer Res (1996) 56 (4): 689–693.
Published: 01 February 1996
View article titled, A Comparative Study of <em>p53</em> Gene Mutations, Protein Accumulation, and Response to Cisplatin-based Chemotherapy in Advanced Ovarian Carcinoma
Open the PDF for A Comparative Study of <em>p53</em> Gene Mutations, Protein Accumulation, and Response to Cisplatin-based Chemotherapy in Advanced Ovarian Carcinoma in another window
Journal Articles

Antibody Response against the c-erbB-2 Oncoprotein in Breast Carcinoma Patients

Serenella M. Pupa, Sylvie Ménard, Salvatore Andreola, Maria I. Colnaghi
Journal: Cancer Research
Cancer Res (1993) 53 (24): 5864–5866.
Published: 01 December 1993
View article titled, Antibody Response against the c-<em>erb</em>B-2 Oncoprotein in Breast Carcinoma Patients
Open the PDF for Antibody Response against the c-<em>erb</em>B-2 Oncoprotein in Breast Carcinoma Patients in another window
Journal Articles

Gene Transfection and Expression of the Ovarian Carcinoma Marker Folate Binding Protein on NIH/3T3 Cells Increases Cell Growth in Vitro and in Vivo

Federica Bottero, Antonella Tomassetti, Silvana Canevari, Silvia Miotti, Sylvie Ménard, Maria I. Colnaghi
Journal: Cancer Research
Cancer Res (1993) 53 (23): 5791–5796.
Published: 01 December 1993
View article titled, Gene Transfection and Expression of the Ovarian Carcinoma Marker Folate Binding Protein on NIH/3T3 Cells Increases Cell Growth <em>in Vitro</em> and <em>in Vivo</em>
Open the PDF for Gene Transfection and Expression of the Ovarian Carcinoma Marker Folate Binding Protein on NIH/3T3 Cells Increases Cell Growth <em>in Vitro</em> and <em>in Vivo</em> in another window
Journal Articles

N-(4-Hydroxyphenyl)retinamide Induces Apoptosis of Malignant Hemopoietic Cell Lines Including Those Unresponsive to Retinoic Acid

Domenico Delia, Antonella Aiello, Luciano Lombardi, Pier Giuseppe Pelicci, Francesco Grignani, Fausto Grignani, Franca Formelli, Sylvie Menard, Alberto Costa, Umberto Veronesi, Marco A. Pierotti
Journal: Cancer Research
Cancer Res (1993) 53 (24): 6036–6041.
Published: 01 December 1993
View article titled, <em>N</em>-(4-Hydroxyphenyl)retinamide Induces Apoptosis of Malignant Hemopoietic Cell Lines Including Those Unresponsive to Retinoic Acid
Open the PDF for <em>N</em>-(4-Hydroxyphenyl)retinamide Induces Apoptosis of Malignant Hemopoietic Cell Lines Including Those Unresponsive to Retinoic Acid in another window